Xencor (XNCR)
(Delayed Data from NSDQ)
$20.36 USD
-0.98 (-4.59%)
Updated May 14, 2024 04:00 PM ET
After-Market: $20.33 -0.03 (-0.15%) 5:48 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Brokerage Reports
Xencor, Inc. [XNCR]
Reports for Purchase
Showing records 1 - 20 ( 216 total )
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for XNCR 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
ESMO 2023 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
XmAb808 (B7-H3 x CD28) preclinical platform validation on two fronts
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D